{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:55:37Z","timestamp":1776408937888,"version":"3.51.2"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"CDC","doi-asserted-by":"publisher","award":["OE20-2001"],"award-info":[{"award-number":["OE20-2001"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neisseria gonorrhoeae (GC) rapidly develops antimicrobial resistance, complicating treatment and surveillance. Although interest in resistance-guided therapy is increasing, most infections are treated empirically. Culture-based antimicrobial susceptibility testing (AST) remains essential but is limited by the fastidious nature of GC. Molecular AST shows promise but is constrained by incomplete validation of resistance determinants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review of phenotypic and molecular AST methods for GC using predefined search strategies across Medline, Embase, Cochrane, CINAHL, and Scopus (2009\u20132024). Of 3136 unique manuscripts identified, 80 met inclusion criteria. Data extraction captured test methods, performance characteristics, and reported strengths and limitations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Agar dilution remains the gold standard for GC AST, though its labor-intensive workflow limits routine use. Disk diffusion, gradient diffusion, and broth microdilution offer feasible alternatives but show method- and drug-dependent variability compared with agar dilution, influenced by media and manufacturer differences. Molecular assays reliably predict ciprofloxacin susceptibility via the gyrA S91F mutation, whereas predictive accuracy for other antibiotics is limited due to multigenic resistance mechanisms. Next-generation sequencing expands detection of resistance determinants but is not yet practical for rapid clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Culture-based AST remains the most reliable approach for detecting GC resistance. Molecular methods have targeted utility, primarily for ciprofloxacin, and require broader validation. Standardizing alternative phenotypic methods, improving molecular marker characterization, and strengthening surveillance capacity will be essential to support resistance-guided therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf706","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:59:29Z","timestamp":1765976369000},"page":"S36-S42","source":"Crossref","is-referenced-by-count":1,"title":["Review of Methods for Detecting Antimicrobial Resistance of\n                    <i>Neisseria gonorrhoeae<\/i>"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7198-1123","authenticated-orcid":false,"given":"Kara K","family":"Mitchell","sequence":"first","affiliation":[{"name":"New York State Department of Health, Wadsworth Center , Albany, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5698-872X","authenticated-orcid":false,"given":"Amanda C","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9998-3091","authenticated-orcid":false,"given":"Julio C","family":"Ayala","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-1756","authenticated-orcid":false,"given":"Matthew W","family":"Schmerer","sequence":"additional","affiliation":[{"name":"Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Pandori","sequence":"additional","affiliation":[{"name":"Sacramento County Public Health Laboratory , Sacramento, California ,","place":["USA"]},{"name":"Nevada State Public Health Laboratory , Reno, Nevada ,","place":["USA"]},{"name":"Department of Pathology and Laboratory Medicine, Reno School of Medicine, University of Nevada , Reno, Nevada ,","place":["USA"]},{"name":"Department of Microbiology and Immunology, Reno School of Medicine, University of Nevada , Reno, Nevada ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"2026022409275884300_ciaf706-B1","volume-title":"Sexually transmitted infections surveillance 2023","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"2026022409275884300_ciaf706-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2026022409275884300_ciaf706-B3","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1093\/infdis\/jiaf071","article-title":"High prevalence of ceftriaxone-resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023\u20132024","volume":"232","author":"Laumen","year":"2025","journal-title":"J Infect Dis"},{"key":"2026022409275884300_ciaf706-B4","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae053","article-title":"High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022\u201323: WHO enhanced gonococcal antimicrobial surveillance programme (EGASP)","volume":"6","author":"Ouk","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2026022409275884300_ciaf706-B5","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC's treatment guidelines for gonococcal infection, 2020","volume":"69","author":"St Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026022409275884300_ciaf706-B6","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1093\/cid\/ciac043","article-title":"Management of Neisseria gonorrhoeae in the United States: summary of evidence from the development of the 2020 gonorrhea treatment recommendations and the 2021 centers for disease control and prevention sexually transmitted infection treatment guidelines","volume":"74","author":"Barbee","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026022409275884300_ciaf706-B7","first-page":"590","article-title":"Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-03","key":"2026022409275884300_ciaf706-B8","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"2026022409275884300_ciaf706-B9","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1086\/511430","article-title":"Centers for disease control and prevention sexually transmitted diseases treatment guidelines","volume":"44","author":"Workowski","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"RR-14","key":"2026022409275884300_ciaf706-B10","first-page":"1","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl 6","key":"2026022409275884300_ciaf706-B11","doi-asserted-by":"crossref","first-page":"S577","DOI":"10.1093\/clinids\/12.Supplement_6.S577","article-title":"1989 sexually transmitted diseases treatment guidelines. Introduction","volume":"12","author":"Zenilman","year":"1990","journal-title":"Rev Infect Dis"},{"key":"2026022409275884300_ciaf706-B12","author":"Centers for Disease Control and Prevention"},{"key":"2026022409275884300_ciaf706-B13","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/jac\/dkaf109","article-title":"The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae: past, present and future threats to effective treatment","volume":"80","author":"Fifer","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026022409275884300_ciaf706-B14","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/cid\/ciw864","article-title":"Implementation of a rapid genotypic assay to promote targeted ciprofloxacin therapy of Neisseria gonorrhoeae in a large health system","volume":"64","author":"Allan-Blitz","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026022409275884300_ciaf706-B15","doi-asserted-by":"crossref","first-page":"115262","DOI":"10.1016\/j.diagmicrobio.2020.115262","article-title":"Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx)","volume":"99","author":"Cotton","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026022409275884300_ciaf706-B16","author":"Association of Public Health Laboratories"},{"key":"2026022409275884300_ciaf706-B17","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1097\/OLQ.0000000000001540","article-title":"Impact of anatomic site, specimen collection timing, and patient symptom status on Neisseria gonorrhoeae culture recovery","volume":"48","author":"Nash","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2026022409275884300_ciaf706-B18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/sextrans-2023-055899","article-title":"Impact of time of culture specimen collection on the recovery of Neisseria gonorrhoeae after a positive nucleic acid amplification test","volume":"99","author":"Nadal-Baron","year":"2023","journal-title":"Sex Transm Infect"},{"key":"2026022409275884300_ciaf706-B19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/lam.13789","article-title":"Neisseria gonorrhoeae culture growth rates from asymptomatic individuals with a positive nucleic acid amplification test","volume":"75","author":"Nadal-Baron","year":"2022","journal-title":"Lett Appl Microbiol"},{"key":"2026022409275884300_ciaf706-B20","volume-title":"CLSI M100: performance standards for antimicrobial susceptibility testing","author":"Lewis","year":"2025","edition":"35th ed"},{"key":"2026022409275884300_ciaf706-B21","doi-asserted-by":"crossref","DOI":"10.1099\/acmi.0.000116","article-title":"Gradient diffusion susceptibility testing for Neisseria gonorrhoeae: an accurate alternative to agar dilution in high-MIC strains?","volume":"2","author":"Desjardins","year":"2020","journal-title":"Access Microbiol"},{"key":"2026022409275884300_ciaf706-B22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1099\/jmm.0.000651","article-title":"Accuracy and reproducibility of the Etest to detect drug-resistant Neisseria gonorrhoeae to contemporary treatment","volume":"67","author":"Papp","year":"2018","journal-title":"J Med Microbiol"},{"key":"2026022409275884300_ciaf706-B23","doi-asserted-by":"crossref","first-page":"e01353-19","DOI":"10.1128\/JCM.01353-19","article-title":"Variability in azithromycin susceptibility results for Neisseria gonorrhoeae obtained using gradient MIC strip and agar dilution techniques","volume":"57","author":"McAuliffe","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2026022409275884300_ciaf706-B24","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1097\/OLQ.0000000000001535","article-title":"Implementation and evaluation of gradient strip antimicrobial susceptibility testing in US public health laboratories to respond to resistant gonorrhea","volume":"48","author":"Raphael","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2026022409275884300_ciaf706-B25","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1128\/JCM.02131-13","article-title":"Assessment of Etest as an alternative to agar dilution for antimicrobial susceptibility testing of Neisseria gonorrhoeae","volume":"52","author":"Liu","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2026022409275884300_ciaf706-B26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijantimicag.2010.01.007","article-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae isolates determined by the agar dilution, disk diffusion and Etest methods: comparison of results using GC agar and chocolate agar","volume":"35","author":"Liao","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"2026022409275884300_ciaf706-B27","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.2147\/IDR.S340074","article-title":"Evaluation of the accuracy of various disks and strips for rapid culture-based gonococcal antimicrobial susceptibility screening tests in China","volume":"14","author":"Xu","year":"2021","journal-title":"Infect Drug Resist"},{"key":"2026022409275884300_ciaf706-B28","doi-asserted-by":"crossref","first-page":"e0060623","DOI":"10.1128\/jcm.00606-23","article-title":"Use of genome sequencing to resolve differences in gradient diffusion and agar dilution antimicrobial susceptibility testing performance of Neisseria gonorrhoeae isolates in Alberta, Canada","volume":"61","author":"Ma","year":"2023","journal-title":"J Clin Microbiol"},{"key":"2026022409275884300_ciaf706-B29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/apm.12887","article-title":"Performance characteristics of newer MIC gradient strip tests compared with the Etest for antimicrobial susceptibility testing of Neisseria gonorrhoeae","volume":"126","author":"Jonsson","year":"2018","journal-title":"APMIS"},{"key":"2026022409275884300_ciaf706-B30","doi-asserted-by":"crossref","first-page":"e000969","DOI":"10.1136\/bmjopen-2012-000969","article-title":"Comparative assessment of CDS, CLSI disc diffusion and Etest techniques for antimicrobial susceptibility testing of Neisseria gonorrhoeae: a 6-year study","volume":"2","author":"Singh","year":"2012","journal-title":"BMJ Open"},{"key":"2026022409275884300_ciaf706-B31","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/jac\/dkaa202","article-title":"Comparison of gentamicin MICs by agar dilution and Etest for clinical isolates of Neisseria gonorrhoeae","volume":"75","author":"Kularatne","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2026022409275884300_ciaf706-B32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12866-016-0707-6","article-title":"Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by Etest compared to calibrated dichotomous sensitivity and Clinical Laboratory Standards Institute disc diffusion techniques","volume":"16","author":"Mal","year":"2016","journal-title":"BMC Microbiol"},{"key":"2026022409275884300_ciaf706-B33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mimet.2019.01.001","article-title":"Comparison of Neisseria gonorrhoeae minimum inhibitory concentrations obtained using agar dilution versus microbroth dilution methods","volume":"157","author":"Jacobson","year":"2019","journal-title":"J Microbiol Methods"},{"key":"2026022409275884300_ciaf706-B34","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2147\/IDR.S253811","article-title":"Comparison of microdilution method with Agar dilution method for antibiotic susceptibility test of Neisseria gonorrhoeae","volume":"13","author":"Chen","year":"2020","journal-title":"Infect Drug Resist"},{"key":"2026022409275884300_ciaf706-B35","doi-asserted-by":"crossref","first-page":"106480","DOI":"10.1016\/j.mimet.2022.106480","article-title":"Spectinomycin, gentamicin, and routine disc diffusion testing: an alternative for the treatment and monitoring of multidrug-resistant Neisseria gonorrhoeae?","volume":"197","author":"Martins","year":"2022","journal-title":"J Microbiol Methods"},{"key":"2026022409275884300_ciaf706-B36","doi-asserted-by":"crossref","first-page":"e01398-20","DOI":"10.1128\/JCM.01398-20","article-title":"Testing of in vitro susceptibility of Neisseria gonorrhoeae to azithromycin: comparison of disk diffusion and reference Agar dilution methods","volume":"58","author":"Gianecini","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026022409275884300_ciaf706-B37","article-title":"Genomic analysis of 1710 surveillance-based Neisseria gonorrhoeae isolates from the USA in 2019 identifies predominant strain types and chromosomal antimicrobial-resistance determinants","volume":"9","author":"Reimche","year":"2023","journal-title":"Microb Genom"},{"issue":"8S","key":"2026022409275884300_ciaf706-B38","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/OLQ.0000000000001471","article-title":"Genomic analysis of the predominant strains and antimicrobial resistance determinants within 1479 Neisseria gonorrhoeae isolates from the US gonococcal isolate surveillance project in 2018","volume":"48","author":"Reimche","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2026022409275884300_ciaf706-B39","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/infdis\/jiw420","article-title":"Genomic epidemiology of gonococcal resistance to extended-spectrum cephalosporins, macrolides, and fluoroquinolones in the United States, 2000\u20132013","volume":"214","author":"Grad","year":"2016","journal-title":"J Infect Dis"},{"key":"2026022409275884300_ciaf706-B40","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/infdis\/jiad027","article-title":"Whole-genome sequencing to predict antimicrobial susceptibility profiles in Neisseria gonorrhoeae","volume":"227","author":"Bristow","year":"2023","journal-title":"J Infect Dis"},{"key":"2026022409275884300_ciaf706-B41","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/jac\/dkz108","article-title":"Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae","volume":"74","author":"Ebeyan","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2026022409275884300_ciaf706-B42","first-page":"491","article-title":"Codon 91 gyrase A testing is necessary and sufficient to predict ciprofloxacin susceptibility in Neisseria gonorrhoeae","volume":"215","author":"Allan-Blitz","year":"2017","journal-title":"J Infect Dis"},{"key":"2026022409275884300_ciaf706-B43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/cid\/ciaa596","article-title":"Resistance-guided treatment of gonorrhea: a prospective clinical study","volume":"73","author":"Klausner","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026022409275884300_ciaf706-B44","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/cid\/ciaa1379","article-title":"Erratum to: resistance-guided treatment of gonorrhea: a prospective clinical study","volume":"72","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026022409275884300_ciaf706-B45","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1128\/AAC.42.8.2103","article-title":"Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae","volume":"42","author":"Trees","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2026022409275884300_ciaf706-B46","first-page":"22","article-title":"Molecular mechanisms of drug resistance Neisseria gonorrhoeae history and prospects","volume":"33","author":"Bodoev","year":"2015","journal-title":"Mol Gen Mikrobiol Virusol"},{"key":"2026022409275884300_ciaf706-B47","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/S2666-5247(22)00356-1","article-title":"Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study","volume":"4","author":"Rubin","year":"2023","journal-title":"Lancet Microbe"},{"key":"2026022409275884300_ciaf706-B48","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jac\/dky438","article-title":"Neisseria gonorrhoeae 23S rRNA A2059G mutation is the only determinant necessary for high-level azithromycin resistance and improves in vivo biological fitness","volume":"74","author":"Zhang","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2026022409275884300_ciaf706-B49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2026022409275884300_ciaf706-B50","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(23)00785-5","article-title":"Novel strain of multidrug non-susceptible Neisseria gonorrhoeae in the USA","volume":"24","author":"Reimche","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026022409275884300_ciaf706-B51","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3201\/eid3009.240557","article-title":"Emergence of extensively drug-resistant Neisseria gonorrhoeae, France, 2023","volume":"30","author":"Camelena","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"2026022409275884300_ciaf706-B52","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/S1473-3099(24)00230-5","article-title":"Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Vietnam","volume":"24","author":"Adamson","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026022409275884300_ciaf706-B53","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/JCM.00493-15","article-title":"Molecular assay for detection of genetic markers associated with decreased susceptibility to cephalosporins in Neisseria gonorrhoeae","volume":"53","author":"Peterson","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2026022409275884300_ciaf706-B54","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/jac\/dkaa360","article-title":"Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samples","volume":"75","author":"Peterson","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2026022409275884300_ciaf706-B55","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/jac\/dkaa525","article-title":"Evaluating the generalizability of a multiplex real-time PCR assay for predicting decreased susceptibility to ceftriaxone in a global set of Neisseria gonorrhoeae sequences","volume":"76","author":"Lin","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2026022409275884300_ciaf706-B56","doi-asserted-by":"crossref","first-page":"e0206521","DOI":"10.1128\/spectrum.02065-21","article-title":"Reliability of genetic alterations in predicting ceftriaxone resistance in Neisseria gonorrhoeae globally","volume":"10","author":"Lin","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2026022409275884300_ciaf706-B57","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/jac\/dkx067","article-title":"WGS to predict antibiotic MICs for Neisseria gonorrhoeae","volume":"72","author":"Eyre","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2026022409275884300_ciaf706-B58","doi-asserted-by":"crossref","first-page":"106168","DOI":"10.1016\/j.jinf.2024.106168","article-title":"Understanding the potential role of whole genome sequencing (WGS) in managing patients with Gonorrhoea: a systematic review of WGS use on human pathogens in individual patient care","volume":"88","author":"Osman","year":"2024","journal-title":"J Infect"},{"key":"2026022409275884300_ciaf706-B59","doi-asserted-by":"crossref","first-page":"e01822-19","DOI":"10.1128\/JCM.01822-19","article-title":"Optimizing DNA extraction methods for nanopore sequencing of Neisseria gonorrhoeae directly from urine samples","volume":"58","author":"Street","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2026022409275884300_ciaf706-B60","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/clinchem\/hvaa306","article-title":"Multiplex PCR and nanopore sequencing of genes associated with antimicrobial resistance in Neisseria gonorrhoeae directly from clinical samples","volume":"67","author":"Zhang","year":"2021","journal-title":"Clin Chem"},{"key":"2026022409275884300_ciaf706-B61","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1101\/gr.262865.120","article-title":"High precision Neisseria gonorrhoeae variant and antimicrobial resistance calling from metagenomic nanopore sequencing","volume":"30","author":"Sanderson","year":"2020","journal-title":"Genome Res"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_1\/S36\/67091324\/ciaf706.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/Supplement_1\/S36\/67091324\/ciaf706.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:28:12Z","timestamp":1771943292000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/Supplement_1\/S36\/8496028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":61,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2026,2,24]]},"published-print":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf706","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,15]]},"published":{"date-parts":[[2026,2,15]]}}}